Baillie Gifford & CO Myriad Genetics Inc Transaction History

Baillie Gifford & CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$10.69 - $16.49 $95.9 Million - $148 Million	-8,970,006 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$9.78 - $29.53 $47,217 - $142,570	4,828 Added 0.05%	8,970,006 $128 Million
Q4 2019 Feb 10, 2020	SELL	$20.93 - $35.1 $5.83 Million - $9.78 Million	-278,625 Reduced 3.01%	8,965,178 $244 Million
Q3 2019 Nov 07, 2019	SELL	$22.08 - $47.08 $6.26 Million - $13.3 Million	-283,339 Reduced 2.97%	9,243,803 $265 Million
Q2 2019 Aug 08, 2019	SELL	$22.67 - $35.0 $304,775 - $470,540	-13,444 Reduced 0.14%	9,527,142 $265 Million
Q1 2019 May 01, 2019	BUY	$26.93 - $34.7 $1.5 Million - $1.93 Million	55,642 Added 0.59%	9,540,586 $0
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $1.7 Million - $2.84 Million	-62,249 Reduced 0.65%	9,484,944 $276 Million
Q3 2018 Nov 13, 2018	BUY	$37.57 - $50.34 $3.46 Million - $4.63 Million	92,008 Added 0.97%	9,547,193 $439 Million
Q2 2018 Jul 17, 2018	SELL	$27.75 - $40.17 $2.99 Million - $4.33 Million	-107,778 Reduced 1.13%	9,455,185 $353 Million
Q1 2018 May 10, 2018	SELL	$28.83 - $41.01 $1.81 Million - $2.58 Million	-62,883 Reduced 0.65%	9,562,963 $283 Million
Q4 2017 Feb 13, 2018	BUY	$28.45 - $37.14 $435,541 - $568,576	15,309 Added 0.16%	9,625,846 $331 Million
Q3 2017 Oct 20, 2017	SELL	$24.01 - $36.2 $1.31 Million - $1.98 Million	-54,710 Reduced 0.57%	9,610,537 $348 Million
Q2 2017 Aug 10, 2017	BUY	N/A	9,665,247	9,665,247 $250 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.